Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | ANNUAL REPORT | f20f2022_universe.htm iXBRL | 20-F | 2412483 |
| 2 | DESCRIPTION OF SECURITIES | f20f2022ex2-3_universe.htm | EX-2.3 | 94267 |
| 3 | ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET | f20f2022ex4-11_universe.htm | EX-4.11 | 117812 |
| 4 | ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET | f20f2022ex4-12_universe.htm | EX-4.12 | 149642 |
| 5 | ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET | f20f2022ex4-13_universe.htm | EX-4.13 | 187350 |
| 6 | ENGLISH TRANSLATION OF THE LETTER OF INTENT ON TRANSFER OF EQUITY INTERESTS IN Y | f20f2022ex4-14_universe.htm | EX-4.14 | 34326 |
| 7 | CERTIFICATION | f20f2022ex12-1_universe.htm | EX-12.1 | 7390 |
| 8 | CERTIFICATION | f20f2022ex12-2_universe.htm | EX-12.2 | 7336 |
| 9 | CERTIFICATION | f20f2022ex13-1_universe.htm | EX-13.1 | 3421 |
| 10 | CERTIFICATION | f20f2022ex13-2_universe.htm | EX-13.2 | 3421 |
| 11 | CONSENT OF ALLBRIGHT LAW OFFICES (FUZHOU) | f20f2022ex15-1_universe.htm | EX-15.1 | 5113 |
| 12 | CONSENT OF YCM CPA INC | f20f2022ex15-2_universe.htm | EX-15.2 | 2688 |
| 13 | CONSENT OF FRIEDMAN LLP | f20f2022ex15-3_universe.htm | EX-15.3 | 2159 |
| 14 | GRAPHIC | img_001.jpg | GRAPHIC | 72283 |
| 15 | GRAPHIC | img_002.jpg | GRAPHIC | 71723 |
| 16 | GRAPHIC | img_003.jpg | GRAPHIC | 7423 |
| 17 | GRAPHIC | img_004.jpg | GRAPHIC | 6210 |
| 18 | GRAPHIC | ex4-11_001.jpg | GRAPHIC | 1656 |
| 19 | GRAPHIC | ex4-11_002.jpg | GRAPHIC | 1639 |
| 20 | GRAPHIC | ex4-11_003.jpg | GRAPHIC | 50422 |
| 21 | GRAPHIC | ex4-11_004.jpg | GRAPHIC | 3631 |
| 22 | GRAPHIC | ex4-11_005.jpg | GRAPHIC | 9833 |
| 23 | GRAPHIC | ex4-11_006.jpg | GRAPHIC | 8381 |
| 24 | GRAPHIC | ex4-11_007.jpg | GRAPHIC | 13166 |
| 25 | GRAPHIC | ex4-12_001.jpg | GRAPHIC | 971 |
| 26 | GRAPHIC | ex4-12_002.jpg | GRAPHIC | 1424 |
| 27 | GRAPHIC | ex4-12_003.jpg | GRAPHIC | 1462 |
| 28 | GRAPHIC | ex4-12_004.jpg | GRAPHIC | 1449 |
| 29 | GRAPHIC | ex4-12_005.jpg | GRAPHIC | 1475 |
| 30 | GRAPHIC | ex4-12_006.jpg | GRAPHIC | 1446 |
| 31 | GRAPHIC | ex4-12_007.jpg | GRAPHIC | 1441 |
| 32 | GRAPHIC | ex4-12_008.jpg | GRAPHIC | 1430 |
| 33 | GRAPHIC | ex4-12_009.jpg | GRAPHIC | 4115 |
| 34 | GRAPHIC | ex4-12_010.jpg | GRAPHIC | 1343 |
| 35 | GRAPHIC | ex4-12_011.jpg | GRAPHIC | 2634 |
| 36 | GRAPHIC | ex4-12_012.jpg | GRAPHIC | 1617 |
| 37 | GRAPHIC | ex4-12_013.jpg | GRAPHIC | 2730 |
| 38 | GRAPHIC | ex4-12_014.jpg | GRAPHIC | 6924 |
| 39 | GRAPHIC | ex4-12_015.jpg | GRAPHIC | 4477 |
| 40 | GRAPHIC | ex4-12_016.jpg | GRAPHIC | 6607 |
| 41 | GRAPHIC | ex4-13_001.jpg | GRAPHIC | 19479 |
| 42 | GRAPHIC | ex4-13_002.jpg | GRAPHIC | 21140 |
| 43 | GRAPHIC | ex4-13_003.jpg | GRAPHIC | 8406 |
| 44 | GRAPHIC | ex4-14_001.jpg | GRAPHIC | 5610 |
| 45 | GRAPHIC | ex4-14_002.jpg | GRAPHIC | 5616 |
| 46 | GRAPHIC | ex4-14_003.jpg | GRAPHIC | 2740 |
| 47 | GRAPHIC | ex4-14_004.jpg | GRAPHIC | 3030 |
| 48 | GRAPHIC | ex4-14_005.jpg | GRAPHIC | 5337 |
| 49 | GRAPHIC | ex15-1_001.jpg | GRAPHIC | 130457 |
| 50 | GRAPHIC | ex15-1_002.jpg | GRAPHIC | 43249 |
| 51 | GRAPHIC | ex15-3_001.jpg | GRAPHIC | 8087 |
| 57 | GRAPHIC | ex15-2_001.jpg | GRAPHIC | 5147 |
| Complete submission text file | 0001213900-23-010349.txt | 10138278 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 52 | XBRL SCHEMA FILE | upc-20220930.xsd | EX-101.SCH | 105209 |
| 53 | XBRL CALCULATION FILE | upc-20220930_cal.xml | EX-101.CAL | 45422 |
| 54 | XBRL DEFINITION FILE | upc-20220930_def.xml | EX-101.DEF | 357772 |
| 55 | XBRL LABEL FILE | upc-20220930_lab.xml | EX-101.LAB | 675379 |
| 56 | XBRL PRESENTATION FILE | upc-20220930_pre.xml | EX-101.PRE | 373637 |
| 148 | EXTRACTED XBRL INSTANCE DOCUMENT | f20f2022_universe_htm.xml | XML | 805242 |
EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 20-F | Act: 34 | File No.: 001-40231 | Film No.: 23613073
SIC: 2834 Pharmaceutical Preparations